515 related articles for article (PubMed ID: 26412071)
1. Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression.
Peng GJ; Tian JS; Gao XX; Zhou YZ; Qin XM
Curr Neuropharmacol; 2015; 13(4):514-23. PubMed ID: 26412071
[TBL] [Abstract][Full Text] [Related]
2. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B
Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
Maric NP; Adzic M
Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
[TBL] [Abstract][Full Text] [Related]
5. gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.
Shen Q; Lal R; Luellen BA; Earnheart JC; Andrews AM; Luscher B
Biol Psychiatry; 2010 Sep; 68(6):512-20. PubMed ID: 20579975
[TBL] [Abstract][Full Text] [Related]
6. Ro41-5253, a selective antagonist of retinoic acid receptor α, ameliorates chronic unpredictable mild stress-induced depressive-like behaviors in rats: Involvement of regulating HPA axis and improving hippocampal neuronal deficits.
Ke Q; Li R; Cai L; Wu SD; Li CM
Brain Res Bull; 2019 Mar; 146():302-309. PubMed ID: 30711623
[TBL] [Abstract][Full Text] [Related]
7. The hypothalamic-pituitary-adrenocortical (HPA) system and anti-depressive drug (AD) action.
Reul JM; Söder M; Holsboer F
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():584A-585A. PubMed ID: 1498962
[No Abstract] [Full Text] [Related]
8. Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic-Pituitary-Adrenal Axis Function and Activating BDNF Signaling Pathway.
Zu X; Zhang M; Li W; Xie H; Lin Z; Yang N; Liu X; Zhang W
Neurochem Res; 2017 Nov; 42(11):3233-3244. PubMed ID: 28758176
[TBL] [Abstract][Full Text] [Related]
9. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
Masi G; Brovedani P
CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
[TBL] [Abstract][Full Text] [Related]
10. Novel agents in development for the treatment of depression.
Grady MM; Stahl SM
CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
[TBL] [Abstract][Full Text] [Related]
11. JIEYUANSHEN DECOCTION EXERTS ANTIDEPRESSANT EFFECTS ON DEPRESSIVE RAT MODEL VIA REGULATING HPA AXIS AND THE LEVEL OF AMINO ACIDS NEUROTRANSMITTER.
Qiuxia Z; Xinlong M; Yilong Y; Hui Z; Yali W; Xiaoquan Y; Lei W; Jiahui C; Haiyan Z
Afr J Tradit Complement Altern Med; 2017; 14(2):33-46. PubMed ID: 28573220
[TBL] [Abstract][Full Text] [Related]
12. N-3 PUFA Have Antidepressant-like Effects Via Improvement of the HPA-Axis and Neurotransmission in Rats Exposed to Combined Stress.
Kim EY; Choi JE; Kim M; Hong J; Park Y
Mol Neurobiol; 2020 Sep; 57(9):3860-3874. PubMed ID: 32613466
[TBL] [Abstract][Full Text] [Related]
13. Crassifoside H improve the depressive-like behavior of rats under chronic unpredictable mild stress: Possible involved mechanisms.
Zhang Y; Ge JF; Wang FF; Liu F; Shi C; Li N
Brain Res Bull; 2017 Oct; 135():77-84. PubMed ID: 28970041
[TBL] [Abstract][Full Text] [Related]
14. Use of endocrine hormones for treating depression.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Dec; 48(12):13-6. PubMed ID: 21117521
[TBL] [Abstract][Full Text] [Related]
15. Ethanol extract of Rehmannia glutinosa exerts antidepressant-like effects on a rat chronic unpredictable mild stress model by involving monoamines and BDNF.
Wang JM; Pei LX; Zhang YY; Cheng YX; Niu CL; Cui Y; Feng WS; Wang GF
Metab Brain Dis; 2018 Jun; 33(3):885-892. PubMed ID: 29468477
[TBL] [Abstract][Full Text] [Related]
16. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
Barden N; Reul JM; Holsboer F
Trends Neurosci; 1995 Jan; 18(1):6-11. PubMed ID: 7535490
[TBL] [Abstract][Full Text] [Related]
17. Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model.
Jindal A; Mahesh R; Bhatt S; Pandey D
Neurochem Int; 2017 Dec; 111():3-11. PubMed ID: 27988361
[TBL] [Abstract][Full Text] [Related]
18. The design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature.
Belzung C; Billette de Villemeur E
Behav Pharmacol; 2010 Dec; 21(8):677-89. PubMed ID: 21051994
[TBL] [Abstract][Full Text] [Related]
19. Piper sarmentosum Roxb. produces antidepressant-like effects in rodents, associated with activation of the CREB-BDNF-ERK signaling pathway and reversal of HPA axis hyperactivity.
Li Q; Qu FL; Gao Y; Jiang YP; Rahman K; Lee KH; Han T; Qin LP
J Ethnopharmacol; 2017 Mar; 199():9-19. PubMed ID: 28126450
[TBL] [Abstract][Full Text] [Related]
20. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
